Molecular Defects in Cardiovascular Disease

Molecular Defects in Cardiovascular Disease provides an in-depth discussion of the molecular mechanisms underlying the genesis of cardiovascular defects and the implications this has on current and emerging targeted therapeutics.  Divided into three sections, this book covers the scientific foundati...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Dhalla, Naranjan S. (Editor ), Nagano, Makoto (Editor ), Ostadal, Bohuslav (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York, NY : Springer New York : Imprint: Springer, 2011.
Edición:1st ed. 2011.
Temas:
Cardiology.
Clinical biochemistry.
Medical Biochemistry.
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-1-4419-7130-2
003 DE-He213
005 20220127125925.0
007 cr nn 008mamaa
008 110804s2011 xxu| s |||| 0|eng d
020 |a 9781441971302  |9 978-1-4419-7130-2 
024 7 |a 10.1007/978-1-4419-7130-2  |2 doi 
050 4 |a RC666-701.2 
072 7 |a MJD  |2 bicssc 
072 7 |a MED010000  |2 bisacsh 
072 7 |a MJD  |2 thema 
082 0 4 |a 616.12  |2 23 
245 1 0 |a Molecular Defects in Cardiovascular Disease  |h [electronic resource] /  |c edited by Naranjan S. Dhalla, Makoto Nagano, Bohuslav Ostadal. 
250 |a 1st ed. 2011. 
264 1 |a New York, NY :  |b Springer New York :  |b Imprint: Springer,  |c 2011. 
300 |a XVIII, 382 p. 78 illus., 31 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Calcium overloading-induced oxidative stress-mediated cellular and subcellular remodeling -- Intracellular MMP-2:  Role in normal and diseased hearts -- Control of the mesenchymal-derived cell phenotype by Ski and Meox2: A putative mechanism for post-developmental phenoconversion -- Elevated Na+/H+ exchanger expression and its role in myocardial disease.- Impact of perinatal chronic hypoxia on cardiac tolerance to acute ischemia -- Stem cell, microRNA and redox cycling -- Cardiac cell therapy: Present and future -- Macroscopic and microscopic aspects of cardiac dysfunction in congestive heart failure -- Cardiac dysfunction and metabolism: Unravelling the molecular cross-talk -- Metabolic remodeling of the hypertrophied heart -- Mechanisms for the regulation of phospholipase C gene expression in cardiac hypertrophy -- Molecular changes in fatty acid oxidation in the failing heart -- Cardiolipin metabolism in experimental and human heart failure -- Mechanisms underlying development of cardiomyocyte hypertrophy via Na-H exchange stimulation -- The structural basis of cardiac dysfunction in human heart failure -- Hormonal mechanisms of cardiac remodeling in heart failure -- Modulators of remodeling after myocardial infarction -- Phosphodiesterase-5 inhibitors in protection against doxorubicin-induced cardiomyopathy -- Molecular basis of pulmonary hypertension in left heart failure -- Modulation of Gi protein expression in hypertension: Molecular mechanisms -- Vascular dysfunction in heart disease -- Cellular and molecular mechanisms associated with salicylate inhibition of intimal hyperplasia balloon catheter-induced vascular injury -- Involvement of growth factor receptor and non receptor protein tyrosine kinases in endothelin 1 and angiotensin II-induced signaling pathways in the cardiovascular system -- Sarco/endoplasmic reticulum Ca2+ pump damage by oxidative stress: Implications for Ca2+ entry -- Obesity-hypertension: Leptin as the common link to cardiovascular and renal dysregulation -- Cardiorenal protection in diabetes mellitus -- Molecular mechanisms in the pathogenesis of diabetic cardiomyopathy. 
520 |a Molecular Defects in Cardiovascular Disease provides an in-depth discussion of the molecular mechanisms underlying the genesis of cardiovascular defects and the implications this has on current and emerging targeted therapeutics.  Divided into three sections, this book covers the scientific foundations of our present understanding as well as the array of clinical manifestations and their treatment.  The first section covers Molecular Mechanisms of Heart Disease, with discussion of the development of cardiovascular dysfunction.  The remaining two sections provide a more clinical focus.  The second, Cardiac Hypertrophy and Heart Failure deals with metabolic derangements, Ca2+ handling, and subcellular remodeling.  It illustrates the wide variety of molecular defects which may serve as targets associated with the transition from cardiac hypertrophy to advanced heart failure.  The third section, Hypertension and Diabetes, provides molecular rationale for the pathogenesis of hypertension and diabetic cardiomyopathy, as well as highlighting the importance of hormones toward this end.    A necessary resource for clinicians and researchers, this book elucidates the experimental basis of the practice of cardiology.  It is the culmination of our advances in the understanding of cardiovascular molecular biology and a blueprint for the efficacious use of targeted therapies. 
650 0 |a Cardiology. 
650 0 |a Clinical biochemistry. 
650 1 4 |a Cardiology. 
650 2 4 |a Medical Biochemistry. 
700 1 |a Dhalla, Naranjan S.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Nagano, Makoto.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Ostadal, Bohuslav.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9781441971296 
776 0 8 |i Printed edition:  |z 9781441971319 
776 0 8 |i Printed edition:  |z 9781493941155 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-1-4419-7130-2  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714) 

Ejemplares similares